Send the following on WhatsApp
Continue to Chathttps://www.zonebourse.com/cours/action/BIONTECH-SE-66771992/actualite/Pfizer-et-BioNTech-SE-recoivent-un-avis-positif-du-CHMP-pour-le-rappel-du-vaccin-bivalent-Covid-19-41759827/?utm_source=whatsapp&utm_medium=social&utm_campaign=share